Related Experiment Video
Updated: Oct 25, 2025
08:29
SUMO-Binding Entities SUBEs as Tools for the Enrichment, Isolation, Identification, and Characterization of the SUMO Proteome in Liver Cancer
Published on: November 1, 2019
7.3K
SUMOylation Is Associated with Aggressive Behavior in Chondrosarcoma of Bone
Jessie S Kroonen1, Alwine B Kruisselbrink2, Inge H Briaire-de Bruijn2
1Department of Cell and Chemical Biology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Cancers
|August 7, 2021
Summary
SUMOylation (SUMO) proteins are deregulated in cancer. Higher SUMO1 and SUMO2/3 expression in chondrosarcomas correlates with tumor grade and poorer survival, suggesting SUMO inhibition as a potential therapeutic strategy.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- SUMOylation machinery components are deregulated in various cancers.
- Understanding SUMOylation's role in tumor progression is crucial for identifying therapeutic targets.
- Chondrosarcomas are malignant cartilage tumors where aggressiveness correlates with histological grade.
Purpose of the Study:
- To investigate the role of SUMOylation in chondrosarcoma progression and aggressiveness.
- To assess SUMO1 and SUMO2/3 expression in relation to histological grade and patient survival.
- To evaluate the efficacy of SUMO inhibition in chondrosarcoma cell lines.
Main Methods:
- Immunohistochemistry on 137 chondrosarcoma tissue microarrays.
- Statistical analysis including log-rank and Cox regression.
- In vitro studies on 7 chondrosarcoma cell lines assessing sensitivity to SUMO inhibition.
Main Results:
- Higher expression of SUMO1 and SUMO2/3 correlated with increased histological grade in chondrosarcomas.
- High SUMO2/3 expression was associated with decreased overall survival (p = 0.0312).
- Chondrosarcoma cell lines, particularly from dedifferentiated tumors, showed sensitivity to SUMO inhibition, with E1 inhibition causing cell division interference and DNA bridges.
Conclusions:
- SUMOylation plays a significant role in chondrosarcoma progression and aggressiveness.
- SUMO expression may serve as a prognostic biomarker for chondrosarcoma.
- SUMO inhibition presents a potential therapeutic avenue for chondrosarcoma treatment.
Related Concept Videos
02:23Abnormal Proliferation
4.8K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
03:03mTOR Signaling and Cancer Progression
4.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.0K
01:29Bone Disorders
4.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
4.4K
02:07Tumor Progression
6.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.7K
01:24Bone Formation by Endochondral Ossification
6.8K
Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
6.8K
01:03Rous Sarcoma Virus (RSV) and Cancer
5.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
5.6K